Create therapies that will reach all patients.
Our mission is to demystify the complexities of market access, making it comprehensible and attainable for all.
F E A T U R E S
Questions we can help you answer
Disease
Are you in the right disease area? Is there a commercial value in your drug solution?
Patients
Is there a well defined unmet need that your drug can address? Is there a patient subpopulation with a high unmet need that you should focus on?
Clinical design
Have you aligned your clinical trial planning to meet both marketing authorisation and pricing and reimbursement requirements? Do you know what clinical evidence you need to provide to national reimbursement authorities?
Value proposition
What are the benefits and the value that your drug adds to patients, KOLs, payers, and the healthcare system as a whole?
Market
Have you analyzed the market and competition? Have you identified target markets and tailored your development strategies to meet their needs and regulatory requirements?
Price
What is a sustainable price for your drug? What are the implications of the price regulation in Europe? How to balance drug affordability with profitability?
Drug reimbursement list
Why do you need a drug to be reimbursed by a compulsory health insurance? What does it take to get the positive reimbursement decision? When do you need to start planning the reimbursement strategy?
Our services.
Sur customized services bring together our extensive biotech experience with regulated reimbursement requirements.
Product strategy and valuation
Value proposition
Clinical trial design and necessary clinical evidence
Evidence gap analysis
Stakeholder communication tools
Payer and access landscape
Stakeholder identification and primary research
Competitor landscaping
Analogues and comparators access hurdles and solutions
Evidence gap analysis
Pricing and reimbursement
Health technology assessment (HTA) planning
HTA landscaping
Pricing scenario planning
Reimbursement strategies and scenarios
Ownership for Market Access Strategy
Lead the Market Access function
Ongoing monitoring and adaptability to ever-changing market dynamics
Competitive intelligence
Thought leadership
Charting new frontiers in market access excellence for pharma, biotech and investors.
